A detailed history of Sachetta, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sachetta, LLC holds 5,788 shares of ABBV stock, worth $981,818. This represents 0.45% of its overall portfolio holdings.

Number of Shares
5,788
Previous 5,587 3.6%
Holding current value
$981,818
Previous $1.04 Billion 9.39%
% of portfolio
0.45%
Previous 0.45%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$163.84 - $199.33 $32,931 - $40,065
201 Added 3.6%
5,788 $1.14 Billion
Q2 2024

Aug 07, 2024

BUY
$154.79 - $180.76 $49,532 - $57,843
320 Added 6.08%
5,587 $1.04 Billion
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $724,739 - $816,226
5,267 New
5,267 $816 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sachetta, LLC Portfolio

Follow Sachetta, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sachetta, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sachetta, LLC with notifications on news.